Double Blind Study of Trp01 in Patients With Alzheimer's Disease
Double Blind Medium Term Efficacy Study of Trp01 in Patients With Mild to Moderate Alzheimer's Disease
Sponsor: Queen's University
Listed as NCT00202124, this PHASE4 trial focuses on Alzheimer's Disease and remains completed. Sponsored by Queen's University, it has been updated 6 times since 2001, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
6 versions recorded-
Jun 2025 — Present [monthly]
Completed PHASE4
-
Apr 2025 — Jun 2025 [monthly]
Completed PHASE4
-
Sep 2024 — Apr 2025 [monthly]
Completed PHASE4
-
Jul 2024 — Sep 2024 [monthly]
Completed PHASE4
-
Jan 2021 — Jul 2024 [monthly]
Completed PHASE4
▶ Show 1 earlier version
-
Jan 2017 — Jan 2021 [monthly]
Completed PHASE4
First recorded
Apr 2001
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Queen's University
For direct contact, visit the study record on ClinicalTrials.gov .